Skip to content 
OMUFA FY 2026: FDA OTC Drug User Fees, Rates & Key Deadlines
OMUFA FY 2026: FDA OTC Drug User Fees, Rates & Key Deadlines The FDA has published the fiscal year 2026 fee rates under the Over-the-Counter Monograph Drug User Fee Amendments (OMUFA II). The headline changes: facility fees for OTC monograph drug manufacturers have dropped approximately 50% compared to FY 2025, while OTC Monograph Order Request […]
OMUFA FY 2026: FDA OTC Drug User Fees, Rates & Key Deadlines Read More »
